The prognostic significance of BRAF mutation status in stage IIIB-C melanoma

By Niebling MG   Wevers KP   Hoekstra HJ  

Expert Review of Dermatology, Vol. 8, Iss. 2, 2013-04 ,pp. : 127-129

Informa Healthcare

Access to resources Recommend Favorite

High Incidence of Naevi-associated BRAF Wild-type Melanoma and Dysplastic Naevi under Treatment with the Class I BRAF Inhibitor Vemurafenib

By Göppner Daniela   Müller Jan   Krüger Sabine   Franke Ingolf   Gollnick Harald   Quist Sven R.  

Acta Dermato-Venereologica, Vol. 94, Iss. 5, 2014-09 ,pp. : 517-520

Medical Journals Limited

Access to resources Recommend Favorite

Could testing for BAP1 germline mutations be a useful tool for early melanoma diagnosis?

By Ferris Laura K   Kupetsky Erine A   Carbone Michele   Yang Haining  

Expert Review of Dermatology, Vol. 8, Iss. 2, 2013-04 ,pp. : 107-109

Informa Healthcare

Access to resources Recommend Favorite

Amelanotic Melanoma – "To Be or Not to Be"

By Ladoyanni Evmorfia   Abdullah Anthony   Sterne Guy D.   Zaki Irshad  

Acta Dermato-Venereologica, Vol. 86, Iss. 2, 2006-03 ,pp. : 189-190

Medical Journals Limited

Access to resources Recommend Favorite

12. Melanoma

By  

Medical and Surgical Dermatology, Vol. 9, Iss. 2, 2008-04 ,pp. : 104-107

Springer Publishing Company

Access to resources Recommend Favorite